An Alzheimer’s drug deemed too costly for the National Health Service (NHS) can slow progression of dementia by up to eight years, researchers have claimed.
Medicines assessor NICE ruled in June that the benefits of two breakthrough therapies were too modest to justify the price, after trials showed they could delay progression from
A Global Challenge in Numbers
The progress made in cell therapies to treat the most severe cases of diabetes marks a significant scientific milestone. However, it is important to recognize that while a few thousand transplantation of insulin-producing cells can be life-saving for individual patients, such interventions will have limited
M42, a global health leader powered by artificial intelligence (AI), technology and genomics, today announced the official incorporation of M42 Saudi Arabia, marking a new era in its partnership with the Kingdom.
The announcement was made during the Global Health Exhibition (GHE) in Riyadh, underscoring M42’s deepening commitment to
The Technology Innovation Institute (TII), the applied research arm of the Abu Dhabi’s Advanced Technology Research Council (ATRC), today announced the launch of its 2 micrometres (µm) high-power fiber laser sources, an innovation that sets new benchmarks for performance, safety and versatility across medicine manufacturing, and
Researchers from the Keck School of Medicine of the University of Southern California, the University of Zurich and ETH Zurich have co-developed an experimental stem cell therapy that shows promise in repairing damaged brain tissue after strokes.
According to a study published in the journal Nature Communications, transplanting neural stem
